Clinical Trial Update: BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BLINAtumomab after R-CHOP debulking therapy for Richter transformation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Richter Syndrome

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Richter Syndrome | Phase 2 | Status: COMPLETED